BOULDER, Colo., Sept. 05, 2023 (GLOBE NEWSWIRE) — SomaLogic, Inc., a leader in proteomics technology, announced today that it is extending its collaborative agreement with global healthcare innovator, Novo Nordisk. As part of the agreement, which now extends into the end of 2025, Novo Nordisk will expand its use of…Read More
SomaLogic expands agreement with Novo Nordisk to 2025
